Procter & Gamble CO Form 4 insider transactions

Procter & Gamble Director Christine M. McCarthy was awarded 269 Restricted Stock Units on December 9, 2025, increasing her direct beneficial ownership to 16,808.9761 shares.

Procter & Gamble Director Christopher J. Kempczinski was granted 260 Restricted Stock Units as part of the company's 2025 Stock and Incentive Compensation Plan.

Procter & Gamble Director Joseph Jimenez received a grant of 341 Restricted Stock Units, increasing his beneficial ownership to 36,083.677 shares.

Procter & Gamble Director Craig Arnold was awarded 215 Restricted Stock Units under the company's 2025 Stock and Incentive Compensation Plan.

Procter & Gamble CEO Jon R. Moeller reported multiple transactions involving common stock and restricted stock units, primarily related to tax withholdings and retirement plan awards.

Procter & Gamble's Chief Legal Officer, Susan Street Whaley, reported recent transactions involving company common stock and Restricted Stock Units.

Procter & Gamble CFO Andre Schulten reported multiple transactions involving common stock and restricted stock units, primarily related to tax withholdings and retirement awards.

Procter & Gamble's CEO of Fabric & Home Care, Sundar G. Raman, reported routine transactions involving common stock and Restricted Stock Units, including tax withholdings and RSU conversions.

Procter & Gamble's Chief Human Resources Officer, Balaji Purushothaman, reported routine transactions involving common stock and Restricted Stock Units.

Procter & Gamble's Chief Brand Officer, Marc S. Pritchard, reported recent transactions involving common stock and Restricted Stock Units, including tax-related share withholdings.

Procter & Gamble's CEO of Beauty, Freddy P. Bharucha, disclosed the vesting of Restricted Stock Units and subsequent tax-related share disposition.

Jennifer L. Davis, CEO of Health Care at Procter & Gamble, reported the acquisition and disposition of common stock and restricted stock units.

Procter & Gamble's CEO of Baby, Fem & Family Care, Ma. Fatima Francisco, reported recent acquisitions and disposals of company common stock and Restricted Stock Units.

Procter & Gamble's Chief Research, Development & Innovation Officer, Moses Victor Javier Aguilar, reported several routine stock transactions, including tax withholdings and RSU conversions.

Procter & Gamble's SVP and Chief Accounting Officer, Matthew W. Janzaruk, reported a disposition of 14.1 shares of common stock to cover taxes on a previous Restricted Stock Unit grant.

Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, reported recent transactions involving common stock and Restricted Stock Units, including tax-related share withholdings and dividend equivalent grants.

Procter & Gamble's Chief Financial Officer, Andre Schulten, reported a future sale of 1.2969 shares of common stock on November 10, 2025, at a price of $146.3745 per share, executed under a Rule 10b5-1 plan.

Procter & Gamble's CEO of Baby, Fem & Family Care, Ma. Fatima Francisco, transferred 12,731 shares of common stock to a Spousal Lifetime Access Trust.

Procter & Gamble's SVP Chief Accounting Officer, Matthew W. Janzaruk, sold 725 shares of common stock.

Procter & Gamble Director Patricia A. Woertz acquired 31 shares of common stock through a Restricted Stock Unit award.

Procter & Gamble Director Rajesh Subramaniam was awarded 1,475 shares of common stock as Restricted Stock Units, increasing his beneficial ownership.

Procter & Gamble Director Robert Portman was awarded 1,475 shares of common stock as Restricted Stock Units on October 14, 2025.

Procter & Gamble Director Ashley McEvoy was awarded 1,475 shares of common stock under the company's 2019 Stock and Incentive Compensation Plan.

Procter & Gamble Director Christine M. McCarthy was awarded 1,475 Restricted Stock Units under the company's 2019 Stock & Incentive Compensation Plan.

Procter & Gamble Director Terry J. Lundgren was awarded 31 shares of common stock as Restricted Stock Units, increasing his direct beneficial ownership.

Procter & Gamble Director Debra L. Lee received an award of 1,475 Restricted Stock Units, increasing her beneficial ownership to 9,270.5578 shares.

Procter & Gamble Director Christopher J Kempczinski received an award of 1,475 Restricted Stock Units, increasing his beneficial ownership to 10,641.4401 shares.

Procter & Gamble Director Joseph Jimenez received an award of 1,475 restricted stock units, increasing his direct beneficial ownership to 35,575.9784 shares.

Procter & Gamble Director Amy Chang was awarded 1,475 Restricted Stock Units as part of the company's 2019 Stock and Incentive Compensation Plan.

Procter & Gamble Director Sheila Bonini was granted 1,475 Restricted Stock Units under the company's 2019 Stock and Incentive Compensation Plan.